MDL TrackerProducts Liability

MONAT Hair Care Products

MDL No. 2841  ·  U.S. District Court for the Southern District of Florida
MDL No.
2841
Docket Type
Products Liability
Transferee Judge
Hon. Darrin P. Gayles
Centralized
2018-06-06
Actions Pending
13
As Of
2026-09-01
Funding Considerations

The MONAT docket is a smaller, consumer products matter: claims allege that hair-care products sold through a multi-level-marketing model caused hair loss, scalp irritation, and related injury, combined with sales-practices allegations about how the products and the business opportunity were marketed to independent brand partners and customers. With only thirteen actions on the docket, this is not a docket built for portfolio-scale financing; it is a small population of individual claims.

Funding availability here tracks individual claim strength more than docket-wide dynamics. A cosmetic-injury claim's value depends heavily on the severity and permanence of the alleged harm — temporary scalp irritation supports a materially different valuation than documented, prolonged hair loss — and on the quality of the causal link between product use and injury, which in a personal-care-product case often rests more on dermatological records and product-use history than on the kind of institutional causation record available in a drug or device MDL. That makes individual underwriting, rather than inventory financing, the more realistic path for capital in this docket.

Medical-lien exposure is typically modest relative to a surgical or drug-injury mass tort — dermatological treatment costs rather than hospitalization or revision surgery — which simplifies net-recovery modeling for any funding structure that does get built. Funders should also expect longer diligence timelines relative to claim size in a docket this thin, since there is less comparative pricing data available from claims that have already resolved elsewhere in the litigation. Criterica Capital's mass tort finance product can size an advance against an individual MONAT claim using the same injury-and-causation framework applied to larger product-liability dockets, scaled to the claim population this litigation actually presents.

A structural view of how this docket compares to other consumer-product litigation — available through Criterica Intelligence — is useful context before pricing any individual file here.

Frequently Asked Questions
Is there enough case volume in the MONAT MDL to support portfolio financing?
+
What determines the value of an individual MONAT claim?
+
Are medical liens a significant issue in this docket?
+
Can a law firm get financing against a small book of MONAT claims?
+

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.

Litigation structure and resolution-risk brief on Criterica Intelligence →
Holding MONAT Hair Care Products claims or inventory?
Send the details and our institutional team will respond within one business day.